The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction
- 5 August 2007
- journal article
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 14 (9) , 861-868
- https://doi.org/10.1038/nsmb1284
Abstract
The cardioprotective function of high-density lipoprotein (HDL) is largely attributed to its ability to facilitate transport of cholesterol from peripheral tissues to the liver. However, HDL may become dysfunctional through oxidative modification, impairing cellular cholesterol efflux. Here we report a refined molecular model of nascent discoidal HDL, determined using hydrogen-deuterium exchange mass spectrometry. The model reveals two apolipoprotein A1 (apoA1) molecules arranged in an antiparallel double-belt structure, with residues 159-180 of each apoA1 forming a protruding solvent-exposed loop. We further show that this loop, including Tyr166, a preferred target for site-specific oxidative modification within atheroma, directly interacts with and activates lecithin cholesterol acyl transferase. These studies identify previously uncharacterized structural features of apoA1 in discoidal HDL that are crucial for particle maturation, and elucidate a structural and molecular mechanism for generating a dysfunctional form of HDL in atherosclerosis.Keywords
This publication has 38 references indexed in Scilit:
- CETP Inhibitors to Increase HDL Cholesterol LevelsNew England Journal of Medicine, 2007
- Mechanisms of Disease: HDL metabolism as a target for novel therapiesNature Clinical Practice Cardiovascular Medicine, 2007
- Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and AtherosclerosisPharmacological Reviews, 2006
- Relationship between the concentration and antiatherogenic activity of high-density lipoproteinsCurrent Opinion in Lipidology, 2006
- Formation of Dysfunctional High-Density Lipoprotein by MyeloperoxidaseTrends in Cardiovascular Medicine, 2005
- HDL as a target in the treatment of atherosclerotic cardiovascular diseaseNature Reviews Drug Discovery, 2005
- HDL Cholesterol and Protective Factors in AtherosclerosisCirculation, 2004
- Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin TreatmentCirculation, 2003
- Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary SyndromesJAMA, 2003
- Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.Proceedings of the National Academy of Sciences, 1994